Point72 Middle East FZE’s Chemours CC Stock Holding History

Point72 Middle East FZE’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,873	Closed	-$557K	–	1534
2023 Q3	$557K	Buy	+19,873	New	+$682K	0.02%	774

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Middle East FZE's CC Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Chemours (CC) in Q4 2023, closing a stake of 19,873 shares — an estimated $557K sold.

Point72 Middle East FZE first reported a position in CC in Q3 2023 and held it in 1 quarter. The position peaked at $557K in Q3 2023. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

Point72 Middle East FZE reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
Point72 Middle East FZE sold 19,873 Chemours shares in Q4 2023, an estimated $557K.
Point72 Middle East FZE first reported a position in Chemours in Q3 2023 and held it in 1 quarter.
Point72 Middle East FZE's Chemours position peaked at $557K in Q3 2023.
469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.